News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Physicians May Soon Say Goodbye to the Stethoscope, as Digital Devices Take Over the Job of Monitoring Patient Bodily Functions

One device that uses computer algorithms to analyze bodily sounds has undergone clinical trials and is awaiting clearance by the FDA

Is technology poised to render the iconic stethoscope passé? For centuries, doctors have used stethoscopes for listening to functions in different parts of the body. However, new devices now exist that employ electronic biosensors to “listen” in on those same sounds and analyze them with computer algorithms. The devices then deliver assessments to attending physicians.

The concept remains the same. Place a device against the body, listen for sounds, and use those sounds to identify a patient’s symptoms. Since the goal is to monitor sounds, it is not likely that “digital stethoscopes” will impinge on the clinical laboratory testing services provided by pathologists and medical laboratory scientists. (more…)

Illumina Plans to Tap Consumer Market for its Smartphone-Ready DNA Chip: Will This Create Diagnostic Consulting Opportunities for Pathologists?

Research team at Illumina believes that consumers are ready to access their own gene sequencing data, along with medical lab test data and other diagnostic information

In the field of next-generation gene sequencing, San Diego, California-based Illumina, Inc., (NASDAQ: ILMN) is moving expeditiously to expand into related markets. One such business initiative is to put gene sequencing at the fingertips of consumers via an app and a smartphone.

Although it is expected to take several years to make this feasible, the fact that Illumina is starting to spend money today to serve such a consumer market is a significant fact for pathologists and clinical laboratory executives monitoring developments in the gene sequencing sector.

The company announced plans to develop a chip that plugs into a smartphone and brings genetic medicine to the individual, reported EE Times in a story it published recently. Illumina says it wants to transform smartphones to “molecular stethoscopes” that could eliminate people’s need to visit primary care doctors. (more…)

J. Craig Venter Joins Race to Crack the Puzzle of Human Aging with New Company That Aims to Sequence 100,000 Human Genomes Yearly

Big Data will play major role as Venter’s team sets out to build world’s largest database of human genotypes, microbiomes and phenotypes

For the second time in recent months, another prominent figure has declared his intention to crack the code of human aging. This time it is scientist and entrepreneur J. Craig Venter, Ph.D., known for his role in sequencing the first whole human genome.

Venter will pursue this goal through a brand new company he launched, called Human Longevity, Inc. (HLI), based in La Jolla, California.

Human Longevity, Inc. Will Compete Against Calico

This is a noteworthy development. Pathologists and clinical laboratory managers already know Venter’s competition in this race is a company called Calico that was founded by several entrepreneurs linked to Google. (more…)

Anticipating the Digital Medicine Revolution, Scripps Doctor Prescribes Smartphone Apps as Frequently as Medications

Pathologists will want to engage with physicians as wireless devices and smartphone apps make it possible to maintain continuous surveillance of the body

Pathologists might want to borrow a page from a tech-savvy doctor who was voted the “Most Influential Physician Executive” in 2012. A cardiologist, this physician says he now prescribes mobile applications for his patients almost as frequently as he prescribes therapeutic drugs.

Many clinical laboratory managers will recognize the name of Eric Topol, M.D., who is the Director of the Scripps Translational Science Institute, Professor of Genomics at the Scripps Research Institute, and Chief Academic Officer at Scripps Health, all located in La Jolla, California. Topol has a passion for wireless medical technology. Moreover, he is nationally recognized as a wireless medical technology trailblazer, as well as for his medical expertise.

In fact, in one news clip, NBC News touts him as the nation’s foremost expert in the explosion of wireless medicine. Topol was also selected by GQ Magazine in 2009 as one of the nation’s 12 “Rock Stars of Science.” (more…)

Scripps Physicians Call for Shift in how Clinical Pathology Laboratories Process Cancer Tissue Samples

Pathologists and clinical laboratory managers should fundamentally change how cancer specimens are handled

Three physicians at Scripps Health are calling for pathologists to rethink how they collect and store cancer tissue samples in two significant ways. They say that pathologists need to: 1) move away from formalin-fixed, paraffin-embedded (FFPE) tissue blocks and toward frozen samples; and, 2) start collecting larger samples.

These doctors used the Journal of the American Medical Association as a platform to issue their call for a change in what has been a long-standing standard of practice in anatomic pathology. Given the progressive nature of these opinions, there will certainly be dissenting voices within the pathology profession who are likely to add their voices to this debate.

(more…)

;